ASP Isotopes Inc. Common Stock
ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services. The Nuclear Fuels segment focuses on the research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for … Read more
ASP Isotopes Inc. Common Stock (ASPI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.092x
Based on the latest financial reports, ASP Isotopes Inc. Common Stock (ASPI) has a cash flow conversion efficiency ratio of -0.092x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-8.86 Million) by net assets ($96.60 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
ASP Isotopes Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how ASP Isotopes Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
ASP Isotopes Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ASP Isotopes Inc. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Surgical Science Sweden AB (publ)
PINK:SUSRF
|
-0.001x |
|
HALOSOURCE REG S
F:48H
|
-0.016x |
|
China Zhonghua Geotechnical Engineering Co Ltd
SHE:002542
|
0.007x |
|
Pharmicell
KO:005690
|
0.080x |
|
Huayi Compressor Co Ltd
SHE:000404
|
0.033x |
|
Beijing Bewinner Communications Co Ltd
SHE:002148
|
-0.005x |
|
Cachet Pharmaceutical Co Ltd
SHE:002462
|
0.079x |
|
GRNVLT EN.REN.
F:000
|
N/A |
Annual Cash Flow Conversion Efficiency for ASP Isotopes Inc. Common Stock (2021–2024)
The table below shows the annual cash flow conversion efficiency of ASP Isotopes Inc. Common Stock from 2021 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $51.17 Million | $-16.70 Million | -0.326x | -13.52% |
| 2023-12-31 | $18.83 Million | $-5.41 Million | -0.287x | +4.02% |
| 2022-12-31 | $9.82 Million | $-2.94 Million | -0.299x | -210.90% |
| 2021-12-31 | $6.00 Million | $-577.69K | -0.096x | -- |